Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peptide antigen production by the proteasome: complexity provides efficiency.

Literature DB >> 8854562

Peptide antigen production by the proteasome: complexity provides efficiency.

M Groettrup¹, A Soza, U Kuckelkorn, P M Kloetzel.

Abstract

Mesh：

Substances：

Year: 1996 PMID： 8854562 DOI： 10.1016/0167-5699(96)10051-7

Source DB: PubMed Journal: Immunol Today ISSN： 0167-5699

Keyword Cloud
Cited

× No keyword cloud information.

48 in total

1. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.

Authors: K Schwarz; R de Giuli; G Schmidtke; S Kostka; M van den Broek; K B Kim; C M Crews; R Kraft; M Groettrup
Journal: J Immunol Date: 2000-06-15 Impact factor: 5.422

2. Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome.

Authors: Can Kesmir; Vera van Noort; Rob J de Boer; Paulien Hogeweg
Journal: Immunogenetics Date: 2003-08-30 Impact factor: 2.846

Review 3. The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Authors: Richard A Hopkins; John E Connolly
Journal: Immunol Res Date: 2012-09 Impact factor: 2.829

4. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.

Authors: Sabrina Chiesa; Silvia Morbelli; Sara Morando; Michela Massollo; Cecilia Marini; Arinna Bertoni; Francesco Frassoni; Soraya Tabera Bartolomé; Gianmario Sambuceti; Elisabetta Traggiai; Antonio Uccelli
Journal: Proc Natl Acad Sci U S A Date: 2011-09-29 Impact factor: 11.205

Peptide antigen production by the proteasome: complexity provides efficiency.

1. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.

2. Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome.

Review 3. The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

4. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.

5. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome.

6. Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells.

7. Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and beta.

8. Anti-proteasome autoantibodies contribute to anti-nuclear antibody patterns on human larynx carcinoma cells.

9. Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection.

10. Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.